Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
2001 3
2004 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study.
Georgoulias V, Kouroussis C, Agelidou A, Boukovinas I, Palamidas P, Stavrinidis E, Polyzos A, Syrigos K, Veslemes M, Toubis M, Ardavanis A, Tselepatiotis E, Vlachonikolis I; Lung Cancer Committee of the Hellenic Oncology Research Group. Georgoulias V, et al. Among authors: palamidas p. Br J Cancer. 2004 Aug 2;91(3):482-8. doi: 10.1038/sj.bjc.6602010. Br J Cancer. 2004. PMID: 15238986 Free PMC article. Clinical Trial.
Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study.
Skarlos DV, Samantas E, Kosmidis P, Fountzilas G, Angelidou M, Palamidas P, Mylonakis N, Provata A, Papadakis E, Klouvas G, et al. Skarlos DV, et al. Among authors: palamidas p. Ann Oncol. 1994 Sep;5(7):601-7. doi: 10.1093/oxfordjournals.annonc.a058931. Ann Oncol. 1994. PMID: 7993835 Free article. Clinical Trial.
Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial.
Georgoulias V, Samonis G, Papadakis E, Alexopoulos A, Tsiafaki X, Rapti A, Veslemes M, Grigoratou T, Palamidas P, Kouroussis C, Mavroudis D, Kakolyris S, Giannakakis T, Vlachonikolis J; Greek Cooperative Group for Lung Cancer. Georgoulias V, et al. Among authors: palamidas p. Lung Cancer. 2001 Dec;34 Suppl 4:S47-51. doi: 10.1016/s0169-5002(01)00417-2. Lung Cancer. 2001. PMID: 11742702 Clinical Trial.